Full Question & Answer Text (for Search Engines)
Question 1:
A 55-year-old male presents with persistent, dull pain in his proximal humerus. Radiographs reveal a lytic lesion with punctate and ring-and-arc calcifications, and cortical thickening without clear periosteal reaction. MRI shows a lobulated mass with high signal on T2-weighted images and internal septations enhancing after gadolinium. Core needle biopsy confirms low-grade chondrosarcoma. What is the most appropriate initial surgical management strategy?
Options:
- Intralesional curettage with adjuvant cryotherapy or phenol.
- Marginal excision with bone grafting.
- Wide en bloc resection.
- Amputation.
- Percutaneous radiofrequency ablation.
Correct Answer: Wide en bloc resection.
Explanation:
For a confirmed low-grade chondrosarcoma, especially in a long bone like the humerus, the standard of care is wide en bloc resection. Intralesional curettage carries a high risk of local recurrence due to the infiltrative nature of chondrosarcomas, even low-grade ones, and the difficulty in achieving clear margins intralesionally. Marginal excision may be considered for juxtacortical or surface lesions but is less appropriate for intramedullary lesions. Amputation is generally reserved for extensive, high-grade tumors where limb salvage is not feasible. Radiofrequency ablation is not an established primary treatment for chondrosarcoma.
Question 2:
Which of the following histological features is most indicative of a conventional chondrosarcoma over an enchondroma?
Options:
- Presence of cartilaginous matrix.
- Absence of hematopoietic marrow.
- Hypercellularity with plump nuclei and occasional binucleation.
- Peripheral endochondral ossification.
- Presence of necrosis.
Correct Answer: Hypercellularity with plump nuclei and occasional binucleation.
Explanation:
While cartilaginous matrix is present in both, and hematopoietic marrow is absent in both lesions, hypercellularity with plump nuclei and occasional binucleation is a key histological feature distinguishing low-grade chondrosarcoma from enchondroma. Enchondromas typically have bland, sparsely cellular cartilage. Necrosis, while seen in higher-grade chondrosarcomas, is not typically a feature of low-grade tumors and its presence is concerning for higher grade. Peripheral endochondral ossification can be seen in both, especially in benign lesions.
Question 3:
A 70-year-old patient presents with a rapidly enlarging, painful mass in the distal femur. Imaging reveals an aggressive lytic lesion with cortical destruction and a soft tissue component. Biopsy shows areas of conventional chondrosarcoma juxtaposed with high-grade pleomorphic spindle cell sarcoma. What is the most likely diagnosis?
Options:
- High-grade conventional chondrosarcoma.
- Mesenchymal chondrosarcoma.
- Dedifferentiated chondrosarcoma.
- Clear cell chondrosarcoma.
- Chondroblastic osteosarcoma.
Correct Answer: Dedifferentiated chondrosarcoma.
Explanation:
The presence of a conventional chondrosarcoma component adjacent to a high-grade, non-cartilaginous sarcoma (e.g., undifferentiated pleomorphic sarcoma or osteosarcoma-like component) is pathognomonic for dedifferentiated chondrosarcoma. This variant typically presents in older patients with rapid growth and aggressive behavior. Mesenchymal chondrosarcoma is characterized by small, round blue cells and islands of hyaline cartilage. Clear cell chondrosarcoma is a low-grade tumor with distinctive clear cells, typically found in epiphyses. High-grade conventional chondrosarcoma would primarily show high-grade cartilaginous features throughout. Chondroblastic osteosarcoma would show osteoid production by malignant cells.
Question 4:
Which of the following pre-existing conditions has the highest risk of malignant transformation to a secondary conventional chondrosarcoma?
Options:
- Solitary enchondroma.
- Multiple hereditary exostoses (MHE).
- Solitary osteochondroma.
- Synovial chondromatosis.
- Chondroblastoma.
Correct Answer: Multiple hereditary exostoses (MHE).
Explanation:
Multiple hereditary exostoses (MHE), also known as hereditary multiple osteochondromas, carries the highest risk of malignant transformation among the listed options, with rates reported between 5-25% (some sources up to 30%) for an osteochondroma within the syndrome. Solitary enchondromas have a very low transformation rate (<1%), whereas enchondromas in syndromes like Ollier's disease or Maffucci's syndrome have a higher, but still lower than MHE, risk. Solitary osteochondromas have a malignant transformation rate of approximately 1%. Synovial chondromatosis and chondroblastoma are benign lesions with extremely rare or no documented malignant transformation to chondrosarcoma, respectively.
Question 5:
A 40-year-old male with Ollier's disease presents with increasing pain in his distal femur. Radiographs show a large intramedullary lesion with aggressive features. Biopsy reveals a Grade II chondrosarcoma. Which of the following statements regarding the genetics of this patient's condition is most accurate?
Options:
- It is primarily associated with mutations in the EXT1 or EXT2 genes.
- It is typically linked to somatic mutations in IDH1 or IDH2 genes.
- It is an autosomal dominant disorder.
- It primarily involves a germline mutation in the TP53 gene.
- It is associated with mutations in the COL2A1 gene.
Correct Answer: It is typically linked to somatic mutations in IDH1 or IDH2 genes.
Explanation:
Ollier's disease and Maffucci's syndrome are non-hereditary, sporadic disorders characterized by multiple enchondromas (and hemangiomas in Maffucci's). They are primarily associated with somatic mutations in the IDH1 or IDH2 genes, which are also frequently found in solitary enchondromas and conventional chondrosarcomas. EXT1/EXT2 mutations are associated with Multiple Hereditary Exostoses (MHE). TP53 is associated with Li-Fraumeni syndrome. COL2A1 is associated with various skeletal dysplasias, but not directly with Ollier's or Maffucci's disease transformation risk to chondrosarcoma.
Question 6:
What is the primary role of systemic chemotherapy in the treatment of conventional chondrosarcoma?
Options:
- Adjuvant therapy for all high-grade tumors.
- Neoadjuvant therapy to downstage primary tumors.
- Palliative treatment for unresectable or metastatic disease.
- Primary treatment for mesenchymal chondrosarcoma.
- Primary treatment for low-grade tumors.
Correct Answer: Palliative treatment for unresectable or metastatic disease.
Explanation:
Conventional chondrosarcoma is notoriously resistant to conventional chemotherapy due to its relatively hypocellular and avascular nature. Therefore, systemic chemotherapy has a very limited role. It may be considered for palliative treatment in cases of unresectable or metastatic disease, but its efficacy is generally poor. Chemotherapy is, however, an important component in the treatment of mesenchymal chondrosarcoma (due to its small round cell component) and dedifferentiated chondrosarcoma (due to the high-grade non-cartilaginous component), but this question specifically asks about 'conventional chondrosarcoma'.
Question 7:
A 35-year-old patient presents with a lesion in the epiphysis of the proximal tibia. Radiographs show a lytic lesion with ill-defined margins and punctate calcifications. Biopsy reveals a tumor composed of epithelioid-like chondrocytes with clear cytoplasm, typically arranged in lobules, with prominent reactive bone formation at the periphery. What is the most likely diagnosis?
Options:
- Conventional chondrosarcoma, Grade I.
- Clear cell chondrosarcoma.
- Chondroblastoma.
- Osteosarcoma, chondroblastic type.
- Giant cell tumor of bone.
Correct Answer: Clear cell chondrosarcoma.
Explanation:
The description of a lytic epiphyseal lesion with epithelioid-like chondrocytes with clear cytoplasm and reactive bone formation at the periphery is classic for clear cell chondrosarcoma. Chondroblastoma is also epiphyseal but typically has polygonal cells with distinct cell membranes and often multinucleated giant cells. Conventional chondrosarcoma usually occurs in the metaphysis or diaphysis. Chondroblastic osteosarcoma is highly aggressive and shows malignant osteoid. Giant cell tumor lacks cartilaginous differentiation.
Question 8:
Which of the following surgical margins is generally considered curative for a low-grade (Grade I) conventional chondrosarcoma of the appendicular skeleton, assuming no cortical breach?
Options:
- Intralesional.
- Marginal.
- Wide.
- Radical.
- Contaminant.
Correct Answer: Wide.
Explanation:
While wide excision is the gold standard for most chondrosarcomas, some low-grade (Grade I) conventional chondrosarcomas that are well-contained within the bone and have no cortical breach can potentially be cured with a marginal excision, where the tumor is removed with a rim of healthy tissue. However, this is a nuanced decision often requiring careful intraoperative assessment and frozen sections. Intralesional curettage alone is associated with higher recurrence rates even for low-grade lesions. Wide is always preferred if anatomically feasible. Radical implies removal of the entire compartment, which is usually for very high-grade or extensive lesions. Contaminant is not a surgical margin definition.
Question 9:
A 60-year-old patient undergoes an en bloc resection for a Grade II chondrosarcoma of the proximal tibia. What is the most critical prognostic factor for local recurrence and survival in this patient?
Options:
- Patient's age.
- Tumor size.
- Presence of IDH1 mutation.
- Adequacy of surgical margins.
- Histological subtype.
Correct Answer: Adequacy of surgical margins.
Explanation:
For resectable chondrosarcoma, the adequacy of surgical margins is the single most critical prognostic factor for both local recurrence and overall survival. Positive surgical margins are strongly associated with higher recurrence rates and poorer outcomes. While tumor size, patient age, histological subtype, and IDH mutations can also have prognostic implications, achieving clear surgical margins is paramount in preventing local disease progression and subsequent metastasis.
Question 10:
A lesion is identified in the sacrum of a 45-year-old male. Biopsy confirms chondrosarcoma. What characteristic features might be seen on MRI that distinguish it from a chordoma, which can also occur in the sacrum?
Options:
- Predominantly T1 hypointense and T2 hyperintense signal.
- Presence of calcifications.
- Extension into the pre-sacral space.
- Lobulated morphology.
- Intralesional hemorrhage.
Correct Answer: Presence of calcifications.
Explanation:
Both chondrosarcoma and chordoma can occur in the sacrum and can be T1 hypointense and T2 hyperintense, and can show lobulated morphology and pre-sacral extension. However, the presence of calcifications is a key distinguishing feature of chondrosarcoma, reflecting the cartilaginous matrix. Chordomas rarely calcify. While intralesional hemorrhage can occur in any tumor, it's not a primary distinguishing feature between these two.
Question 11:
Which of the following chondrosarcoma variants is characterized histologically by a biphasic pattern of small, round undifferentiated cells and islands of well-differentiated hyaline cartilage?
Options:
- Conventional chondrosarcoma.
- Dedifferentiated chondrosarcoma.
- Mesenchymal chondrosarcoma.
- Clear cell chondrosarcoma.
- Juxtacortical chondrosarcoma.
Correct Answer: Mesenchymal chondrosarcoma.
Explanation:
Mesenchymal chondrosarcoma is classically described by its biphasic histological pattern: a primitive, small round cell component resembling Ewing sarcoma or hemangiopericytoma, and distinct islands of hyaline cartilage. This unique histology contributes to its more aggressive behavior and responsiveness to chemotherapy, unlike conventional chondrosarcoma. Other variants do not share this specific biphasic morphology.
Question 12:
A 25-year-old female presents with a painful mass on the surface of her distal femur. Radiographs show a broad-based sessile lesion arising from the cortical surface with a cartilaginous cap. There is no evidence of medullary invasion. Biopsy confirms juxtacortical chondrosarcoma. What is the most appropriate surgical approach?
Options:
- Intralesional curettage.
- Wide en bloc resection.
- Marginal excision including the underlying cortex.
- Amputation.
- Radiation therapy as primary treatment.
Correct Answer: Marginal excision including the underlying cortex.
Explanation:
Juxtacortical (or periosteal) chondrosarcoma, although often low-grade, still requires complete excision. Marginal excision including the underlying cortex (cortical saucerization) is typically sufficient to achieve clear margins for these lesions, as they originate from the periosteum and tend to grow outwards rather than invading the medullary cavity significantly. Wide en bloc resection would be overly aggressive for many cases if a marginal excision is feasible with a clear margin. Intralesional curettage is inadequate. Amputation is generally not indicated. Radiation therapy is not a primary treatment for resectable chondrosarcoma.
Question 13:
Which of the following statements regarding the grading of conventional chondrosarcoma is most accurate?
Options:
- Grade I tumors have a high metastatic potential.
- Grading is primarily based on mitotic activity and cellular pleomorphism.
- Grade III tumors are considered benign but locally aggressive.
- The presence of necrosis automatically upstages a tumor to Grade III.
- Grading is predictive of response to chemotherapy.
Correct Answer: Grading is primarily based on mitotic activity and cellular pleomorphism.
Explanation:
The grading of conventional chondrosarcoma (I, II, III) is a crucial prognostic indicator. It is primarily based on cellularity, nuclear size and atypia, and the presence of myxoid changes. Mitotic figures, while present in higher grades, are often scarce even in Grade II. Necrosis, when present, is a strong indicator of Grade III disease and contributes to the diagnosis. Grade I tumors have very low metastatic potential. Grade III tumors are malignant and highly aggressive with significant metastatic potential. Grading for conventional chondrosarcoma is generally not predictive of chemotherapy response, as most conventional chondrosarcomas are chemoresistant.
Question 14:
A 50-year-old male with a history of a solitary osteochondroma in the distal femur presents with new onset pain and an enlarging mass. Radiographs show irregular cortical thickening and a lucency within the cartilaginous cap. What is the most critical measurement on imaging to suggest malignant transformation?
Options:
- Overall size of the osteochondroma.
- Width of the stalk.
- Presence of a bursa over the lesion.
- Thickness of the cartilaginous cap exceeding 2-3 cm in adults.
- Presence of a growth plate within the osteochondroma.
Correct Answer: Thickness of the cartilaginous cap exceeding 2-3 cm in adults.
Explanation:
For a solitary osteochondroma, a cartilaginous cap thickness exceeding 2-3 cm in adults is a strong indicator of malignant transformation to secondary peripheral chondrosarcoma. In children, cap thickness up to 2 cm can be normal. Other factors like increasing size, new pain, erosion of adjacent bone, or irregular calcifications are also suggestive, but cap thickness is a key diagnostic criterion on imaging. The width of the stalk and presence of a bursa are not direct indicators of malignancy. A growth plate within an osteochondroma is normal.
Question 15:
Regarding the surgical management of chondrosarcoma, why is tumor contamination of the surgical field a significant concern?
Options:
- It increases the risk of systemic metastasis.
- It prevents successful limb salvage.
- It significantly increases the risk of local recurrence.
- It always necessitates adjuvant radiation therapy.
- It makes histological diagnosis more challenging.
Correct Answer: It significantly increases the risk of local recurrence.
Explanation:
Chondrosarcomas are known for their propensity for local recurrence, especially if tumor cells are spilled or left behind in the surgical field. Tumor contamination significantly increases the risk of local recurrence, which can be more aggressive and challenging to treat. While systemic metastasis can occur, contamination's primary and most direct impact is on local control. It does not inherently prevent limb salvage, but it complicates it. Adjuvant radiation is not always necessitated, and histological diagnosis is typically performed preoperatively.
Question 16:
Which of the following is considered the most common site for conventional chondrosarcoma?
Options:
- Small bones of the hands and feet.
- Distal femur and proximal tibia.
- Pelvis and proximal femur.
- Vertebrae.
- Ribs.
Correct Answer: Pelvis and proximal femur.
Explanation:
The pelvis and proximal femur are the most common sites for conventional chondrosarcoma, accounting for a significant proportion of cases. While chondrosarcoma can occur in any bone, including small bones, vertebrae, ribs, and long bones, the large flat bones of the pelvis and proximal long bones are classic locations.
Question 17:
A 65-year-old patient with a large, asymptomatic pelvic lesion suspicious for chondrosarcoma is being evaluated. What is the definitive diagnostic procedure?
Options:
- CT scan of the pelvis.
- MRI with contrast.
- PET scan.
- Core needle biopsy.
- Bone scintigraphy.
Correct Answer: Core needle biopsy.
Explanation:
While imaging (CT, MRI) is crucial for characterizing the lesion and surgical planning, the definitive diagnosis of chondrosarcoma (and all bone tumors) relies on histological examination via biopsy. A core needle biopsy is generally preferred over open biopsy to minimize contamination, especially for a pelvic lesion where surgical access can be challenging. Imaging studies are suggestive but not definitive. PET scans are used for staging and assessing metabolic activity, but not for definitive diagnosis. Bone scintigraphy can show increased uptake but is non-specific.
Question 18:
What is a key difference in the clinical presentation of an enchondroma versus a low-grade chondrosarcoma in an adult?
Options:
- Enchondromas are typically painful, while chondrosarcomas are not.
- Low-grade chondrosarcomas are often asymptomatic, while enchondromas usually cause fractures.
- Enchondromas commonly present with pathological fractures; low-grade chondrosarcomas present with localized pain.
- Enchondromas are typically asymptomatic unless complicated by fracture, whereas new or increasing pain in an adult is a red flag for chondrosarcoma.
- Both are typically painful from onset.
Correct Answer: Enchondromas are typically asymptomatic unless complicated by fracture, whereas new or increasing pain in an adult is a red flag for chondrosarcoma.
Explanation:
Enchondromas are typically asymptomatic incidental findings unless they cause a pathological fracture. In contrast, new onset or increasing dull, persistent pain in an adult with a cartilaginous lesion, especially in a central location, is a classic warning sign for malignant transformation to chondrosarcoma, even low-grade. While low-grade chondrosarcomas can be asymptomatic initially, pain is a much more common presentation than with enchondromas, which only become painful with complications.
Question 19:
A patient is found to have a conventional chondrosarcoma. Which of the following statements about its metastatic potential is true?
Options:
- Metastasis is common even in Grade I tumors.
- The most common site of metastasis is regional lymph nodes.
- Metastasis is primarily hematogenous, with the lungs being the most common site.
- Metastasis typically occurs early in the disease course.
- Metastasis is highly responsive to chemotherapy.
Correct Answer: Metastasis is primarily hematogenous, with the lungs being the most common site.
Explanation:
Metastasis from conventional chondrosarcoma is primarily hematogenous, and the lungs are the most common site for metastatic disease. Regional lymph node metastasis is rare. Grade I tumors have a very low metastatic potential. Metastasis tends to occur later in the disease course, particularly with higher-grade tumors or after local recurrences. As previously noted, conventional chondrosarcoma metastases are generally chemoresistant.
Question 20:
In the context of chondrosarcoma, what is the significance of IDH1/IDH2 mutations?
Options:
- They are oncogenic drivers and potential therapeutic targets, frequently found in conventional and dedifferentiated chondrosarcomas.
- They are tumor suppressor genes, and their inactivation leads to malignancy.
- They are primarily found in mesenchymal chondrosarcomas.
- They are genetic markers for differentiating enchondroma from chondrosarcoma, present only in benign lesions.
- They are associated with response to radiation therapy.
Correct Answer: They are oncogenic drivers and potential therapeutic targets, frequently found in conventional and dedifferentiated chondrosarcomas.
Explanation:
Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 genes are frequently found in conventional central chondrosarcomas (up to 70%), dedifferentiated chondrosarcomas, and enchondromas (particularly in Ollier's and Maffucci's diseases). These mutations lead to the production of D-2-hydroxyglutarate (2HG), an oncometabolite, and are considered oncogenic drivers. They represent promising therapeutic targets for specific inhibitors. They are not tumor suppressor genes and are not exclusive to mesenchymal chondrosarcoma, nor are they exclusively found in benign lesions; their presence in enchondromas and low-grade chondrosarcomas highlights the continuum of cartilaginous tumor progression.
Question 21:
A 48-year-old male presents with hip pain and a pelvic mass. Biopsy confirms Grade II chondrosarcoma. Surgical planning involves wide resection. Which of the following imaging modalities is most critical for assessing the extent of soft tissue involvement and neurovascular compromise in complex anatomical locations like the pelvis?
Options:
- Plain radiographs.
- CT scan with intravenous contrast.
- MRI with gadolinium contrast.
- Bone scintigraphy.
- PET-CT.
Correct Answer: MRI with gadolinium contrast.
Explanation:
MRI with gadolinium contrast is the gold standard for assessing soft tissue involvement, defining tumor margins, evaluating neurovascular bundle involvement, and planning surgical approaches in complex anatomical regions like the pelvis for bone and soft tissue tumors. While CT provides excellent bony detail and calcification assessment, MRI is superior for soft tissue contrast. Plain radiographs are initial screening tools. Bone scintigraphy and PET-CT are useful for assessing metabolic activity and metastasis but are less precise for local anatomical detail and margin assessment.
Question 22:
Which histological subtype of chondrosarcoma is known for its relatively indolent course, often affecting the epiphyses of long bones, and may be confused with chondroblastoma?
Options:
- Dedifferentiated chondrosarcoma.
- Mesenchymal chondrosarcoma.
- Conventional chondrosarcoma (Grade III).
- Clear cell chondrosarcoma.
- Juxtacortical chondrosarcoma.
Correct Answer: Clear cell chondrosarcoma.
Explanation:
Clear cell chondrosarcoma is a rare, low-grade variant typically found in the epiphyses of long bones (e.g., proximal humerus, distal femur, proximal tibia) of young to middle-aged adults. Its histological features (clear cells, reactive bone formation, often epiphyseal location) can lead to misdiagnosis as chondroblastoma. It has a relatively indolent course compared to other malignant chondrosarcoma types, but still requires wide excision.
Question 23:
What is the primary reason conventional chondrosarcomas are generally considered radioresistant?
Options:
- They are highly vascular tumors.
- They have a low metabolic rate and low mitotic index.
- They are rapidly proliferating tumors.
- They produce a protective cartilaginous matrix that radiation cannot penetrate.
- They have high expression of DNA repair enzymes.
Correct Answer: They have a low metabolic rate and low mitotic index.
Explanation:
Conventional chondrosarcomas are typically hypocellular and have a relatively low metabolic rate and low mitotic index compared to many other sarcomas. Radiation therapy is most effective against rapidly dividing cells. This inherent biological characteristic makes them relatively radioresistant. While DNA repair mechanisms contribute, the fundamental biological inertness of the chondrocytes within the tumor is the primary factor.
Question 24:
A 58-year-old male with a history of a solitary osteochondroma on his scapula develops a rapidly growing, painful mass. Biopsy reveals features of both chondrosarcoma and undifferentiated pleomorphic sarcoma. What surgical consideration is paramount in this case?
Options:
- Marginal excision to preserve function.
- Intralesional curettage to remove the cartilaginous component.
- Wide en bloc resection with aggressive margins.
- Preoperative radiation therapy to shrink the tumor.
- Neoadjuvant chemotherapy to address the undifferentiated component.
Correct Answer: Wide en bloc resection with aggressive margins.
Explanation:
The description of chondrosarcoma alongside an undifferentiated pleomorphic sarcoma component points to dedifferentiated chondrosarcoma. This is an extremely aggressive variant with a high propensity for metastasis and local recurrence. Therefore, wide en bloc resection with aggressive margins is paramount to achieve local control. Marginal excision or intralesional curettage would be grossly inadequate. While neoadjuvant chemotherapy may be considered for the undifferentiated component, surgical resection with clear margins remains the cornerstone of treatment. Radiation therapy is not typically curative for these lesions as a primary treatment.
Question 25:
Which of the following conditions is most likely to be confused with a low-grade chondrosarcoma on imaging and biopsy, particularly in the short tubular bones?
Options:
- Osteochondroma.
- Giant cell tumor.
- Enchondroma.
- Fibrous dysplasia.
- Chondroblastoma.
Correct Answer: Enchondroma.
Explanation:
Enchondroma is the most challenging differential diagnosis for low-grade chondrosarcoma, especially in the short tubular bones (hands and feet). The distinction can be particularly difficult on biopsy, requiring careful assessment of cellularity, nuclear atypia, and matrix patterns. Osteochondromas are exophytic lesions with a clear bony cortex. Giant cell tumors are typically epiphyseal/metaphyseal, lytic, and lack cartilaginous matrix. Fibrous dysplasia has a characteristic ground-glass matrix. Chondroblastoma is epiphyseal.
Question 26:
What is the defining characteristic of a low-grade (Grade I) conventional chondrosarcoma on histological examination?
Options:
- High mitotic activity and extensive necrosis.
- Marked cellular pleomorphism and prominent spindle cell component.
- Mildly increased cellularity with plump nuclei, occasional binucleation, and permeation of marrow spaces.
- Sheets of small, round blue cells with interspersed cartilage islands.
- Epithelioid cells with clear cytoplasm in an epiphyseal location.
Correct Answer: Mildly increased cellularity with plump nuclei, occasional binucleation, and permeation of marrow spaces.
Explanation:
Grade I conventional chondrosarcoma is characterized by mildly increased cellularity compared to enchondroma, with plump nuclei, occasional binucleation, and a hallmark feature is the permeation of marrow fat spaces by tumor cells. High mitotic activity, necrosis, and marked pleomorphism are features of higher grades (II and III). Small round blue cells and cartilage islands define mesenchymal chondrosarcoma. Epithelioid clear cells define clear cell chondrosarcoma.
Question 27:
Regarding chondrosarcoma staging, which system is most commonly used by orthopedic oncologists and provides prognostic information primarily based on tumor grade and local extent?
Options:
- TNM staging system (AJCC/UICC).
- Enneking Staging System (Musculoskeletal Tumor Society).
- Duke's staging system.
- Ann Arbor staging system.
- Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grading system.
Correct Answer: Enneking Staging System (Musculoskeletal Tumor Society).
Explanation:
The Enneking Staging System (Musculoskeletal Tumor Society) is widely used by orthopedic oncologists for primary bone and soft tissue sarcomas. It classifies tumors based on grade (G), local extent (T, Intracapsular/Intracompartmental/Extracompartmental), and presence of metastasis (M). The TNM system (AJCC) is also used but the Enneking system specifically addresses the unique considerations of musculoskeletal sarcomas for surgical planning. Duke's is for colorectal cancer, Ann Arbor for lymphoma, and FNCLCC is a grading system primarily for soft tissue sarcomas.
Question 28:
A 75-year-old male presents with persistent sacral pain. Imaging shows a large, destructive lesion in the sacrum with amorphous calcifications. Biopsy confirms Grade II chondrosarcoma. Due to the size and location, a complete en bloc resection would be highly morbid. What is a potential adjuvant therapy that might be considered if clear surgical margins are difficult to obtain?
Options:
- Standard fractionated external beam radiation therapy.
- High-dose systemic chemotherapy.
- Immunotherapy.
- Proton beam therapy or carbon ion therapy.
- Targeted therapy against IDH mutations.
Correct Answer: Proton beam therapy or carbon ion therapy.
Explanation:
While conventional chondrosarcoma is generally radioresistant, advanced radiation techniques like proton beam therapy or carbon ion therapy offer superior dose conformity and allow for higher doses to be delivered to the tumor while sparing critical adjacent structures (like the spinal cord or bowel in sacral tumors). These can be considered, particularly in cases where complete surgical resection with clear margins is challenging or impossible. Standard fractionated external beam radiation has limited efficacy. Systemic chemotherapy and immunotherapy have limited roles for conventional chondrosarcoma. Targeted IDH inhibitors are emerging but are not yet standard adjuvant therapy and depend on specific mutations.
Question 29:
Which of the following is characteristic of a mesenchymal chondrosarcoma?
Options:
- Predominantly affects elderly patients in the flat bones.
- Has a biphasic histology with small round cells and islands of hyaline cartilage.
- Is typically a low-grade tumor with excellent prognosis.
- Is resistant to both chemotherapy and radiation therapy.
- Usually presents in the epiphysis of long bones.
Correct Answer: Has a biphasic histology with small round cells and islands of hyaline cartilage.
Explanation:
Mesenchymal chondrosarcoma is characterized by its distinct biphasic histology. It tends to affect younger patients (2nd-3rd decades), can occur in various locations including the axial skeleton and soft tissues, and is considered high-grade. Unlike conventional chondrosarcoma, it can be sensitive to chemotherapy and, to a lesser extent, radiation, due to its small round cell component. It does not typically present in the epiphysis.
Question 30:
A 30-year-old patient has a suspected chondrosarcoma in the femoral shaft. Which imaging characteristic on MRI would be most concerning for a high-grade lesion rather than a low-grade one?
Options:
- Endosteal scalloping of the cortex.
- Lobulated growth pattern with internal septa.
- Well-defined sclerotic border.
- Cortical destruction and extraosseous extension.
- Punctate calcifications within the matrix.
Correct Answer: Cortical destruction and extraosseous extension.
Explanation:
Cortical destruction and extraosseous extension into surrounding soft tissues are hallmark signs of an aggressive, higher-grade chondrosarcoma. Endosteal scalloping, lobulated growth pattern, and punctate calcifications can be seen in both low-grade chondrosarcomas and even some enchondromas, though more pronounced scalloping and lobulation suggest malignancy. A well-defined sclerotic border is usually a feature of a benign lesion or a very indolent process, not a high-grade chondrosarcoma.
Question 31:
Which of the following is NOT typically considered a primary treatment modality for resectable conventional chondrosarcoma?
Options:
- Wide surgical resection.
- Marginal surgical resection (in select low-grade cases).
- Intralesional curettage with adjuvant therapy (e.g., cryoablation) for specific low-grade lesions.
- Systemic chemotherapy.
- Amputation (for extensive disease).
Correct Answer: Systemic chemotherapy.
Explanation:
Systemic chemotherapy has a very limited role in the primary treatment of resectable conventional chondrosarcoma due to its chemoresistance. The primary treatment modalities are surgical: wide resection is the gold standard, marginal resection may be considered for very select low-grade lesions, and intralesional curettage with adjuvants is sometimes used for specific low-grade central lesions in expendable bones. Amputation is reserved for extensive, high-grade, or recurrent tumors where limb salvage is not feasible. The question asks what is NOT typically considered primary treatment, making chemotherapy the correct answer.
Question 32:
What is the typical prognosis for patients with dedifferentiated chondrosarcoma compared to conventional Grade I chondrosarcoma?
Options:
- Dedifferentiated chondrosarcoma has a significantly better prognosis.
- Both have similar excellent prognoses.
- Dedifferentiated chondrosarcoma has a significantly worse prognosis.
- Dedifferentiated chondrosarcoma has a better prognosis only if treated with chemotherapy.
- The prognosis is solely dependent on tumor size, not subtype.
Correct Answer: Dedifferentiated chondrosarcoma has a significantly worse prognosis.
Explanation:
Dedifferentiated chondrosarcoma has a significantly worse prognosis than conventional Grade I chondrosarcoma. It is an aggressive, high-grade tumor with a high metastatic rate and poor overall survival, despite aggressive surgical and often systemic therapy. Conventional Grade I chondrosarcoma, if adequately resected, has an excellent prognosis with very low metastatic potential.
Question 33:
A 40-year-old female presents with a slowly growing, painful mass in her chest wall. Imaging shows a rib lesion with chondroid matrix and cortical expansion. Biopsy confirms Grade II chondrosarcoma. What surgical principle is most important for local control in this patient?
Options:
- Achieving an intralesional margin to remove the bulk of the tumor.
- Performing a wide en bloc resection of the affected rib with clear margins.
- Debulking the tumor followed by radiation therapy.
- Administering neoadjuvant chemotherapy before surgery.
- Performing a marginal excision without bone reconstruction.
Correct Answer: Performing a wide en bloc resection of the affected rib with clear margins.
Explanation:
For a Grade II chondrosarcoma of the rib, wide en bloc resection with clear margins is essential for local control. This typically involves removing the entire affected rib section, including surrounding soft tissue. Intralesional margins are inadequate and lead to high recurrence rates. Debulking followed by radiation is generally not effective for conventional chondrosarcoma. Neoadjuvant chemotherapy is not standard for conventional chondrosarcoma. Marginal excision might be considered for very low-grade, non-aggressive lesions, but for Grade II, wide margins are critical, and bone reconstruction is a separate consideration for stability.
Question 34:
Which of the following syndromes is associated with an increased risk of multiple enchondromas and subsequent malignant transformation to chondrosarcoma, often presenting with soft tissue hemangiomas?
Options:
- Multiple Hereditary Exostoses (MHE).
- Li-Fraumeni syndrome.
- Ollier's disease.
- Maffucci's syndrome.
- Paget's disease of bone.
Correct Answer: Maffucci's syndrome.
Explanation:
Maffucci's syndrome is characterized by the presence of multiple enchondromas (similar to Ollier's disease) and soft tissue spindle cell hemangiomas. Both Ollier's disease and Maffucci's syndrome carry a significant risk of malignant transformation of enchondromas into chondrosarcoma, with Maffucci's often cited as having a higher risk (20-50%). MHE is associated with osteochondromas. Li-Fraumeni is associated with various sarcomas and carcinomas (TP53 mutation). Paget's disease increases the risk of osteosarcoma, not chondrosarcoma primarily.
Question 35:
What is the typical age range for the presentation of conventional chondrosarcoma?
Options:
- Childhood (0-10 years).
- Adolescence (10-20 years).
- Young adults (20-40 years).
- Middle to older adulthood (40-70+ years).
- Any age, with no clear peak.
Correct Answer: Middle to older adulthood (40-70+ years).
Explanation:
Conventional chondrosarcoma typically presents in middle to older adulthood, with a peak incidence in the 5th to 7th decades of life (40-70+ years). While it can occur in younger individuals, especially in the setting of syndromes like Ollier's or Maffucci's, it is rare in childhood and adolescence. Other variants like mesenchymal chondrosarcoma may affect younger populations.
Question 36:
Which of the following is an expected radiographic finding for a low-grade conventional chondrosarcoma?
Options:
- Extensive Codman's triangle.
- Hair-on-end periosteal reaction.
- Well-circumscribed lytic lesion with punctate/ring-and-arc calcifications and endosteal scalloping.
- Sunburst periosteal reaction.
- Sclerotic lesion with a thick, benign-appearing periosteal reaction.
Correct Answer: Well-circumscribed lytic lesion with punctate/ring-and-arc calcifications and endosteal scalloping.
Explanation:
Low-grade conventional chondrosarcomas commonly present radiographically as well-circumscribed lytic lesions with characteristic punctate or ring-and-arc calcifications (representing mineralized cartilaginous matrix) and varying degrees of endosteal scalloping, indicating internal bone erosion. Codman's triangle, hair-on-end, and sunburst periosteal reactions are typical of more aggressive lesions like osteosarcoma or Ewing sarcoma. A thick, benign-appearing periosteal reaction might suggest chronic osteomyelitis or a healing fracture, not a chondrosarcoma.
Question 37:
A patient with a presumed enchondroma in a long bone develops symptoms consistent with malignant transformation. What is the most appropriate next diagnostic step after initial radiographs?
Options:
- Immediate surgical curettage.
- Observation with serial radiographs every 6 months.
- MRI of the affected bone with contrast.
- Bone scan to rule out metastases.
- CT angiogram to assess vascularity.
Correct Answer: MRI of the affected bone with contrast.
Explanation:
If clinical symptoms (pain) or initial radiographs suggest malignant transformation of an enchondroma, an MRI with contrast is the most appropriate next step. MRI provides superior soft tissue resolution, can assess the extent of intramedullary involvement, detect cortical breach, evaluate soft tissue extension, and often helps differentiate between benign and malignant cartilaginous lesions based on enhancement patterns and presence of soft tissue mass. Immediate surgical curettage without full workup risks inadequate treatment. Observation is inappropriate with suspicious symptoms. A bone scan might be part of staging but MRI is better for local assessment. CT angiogram is not routinely indicated for diagnosis.
Question 38:
What is the most common histological variant of chondrosarcoma?
Options:
- Clear cell chondrosarcoma.
- Mesenchymal chondrosarcoma.
- Dedifferentiated chondrosarcoma.
- Conventional chondrosarcoma.
- Juxtacortical chondrosarcoma.
Correct Answer: Conventional chondrosarcoma.
Explanation:
Conventional chondrosarcoma is by far the most common histological variant, accounting for approximately 85-90% of all chondrosarcomas. The other variants (clear cell, mesenchymal, dedifferentiated, juxtacortical/periosteal) are relatively rare.
Question 39:
Which of the following statements about radiation therapy for chondrosarcoma is true?
Options:
- Conventional chondrosarcoma is highly radiosensitive and radiation is the primary treatment.
- Radiation therapy is contraindicated in all forms of chondrosarcoma.
- Mesenchymal chondrosarcoma and dedifferentiated chondrosarcoma may show some response to radiation due to their more aggressive, less differentiated components.
- Radiation therapy is effective for local control of Grade I lesions but not higher grades.
- Radiation therapy is used exclusively for palliation of pain in metastatic disease.
Correct Answer: Mesenchymal chondrosarcoma and dedifferentiated chondrosarcoma may show some response to radiation due to their more aggressive, less differentiated components.
Explanation:
While conventional chondrosarcoma is generally considered radioresistant, mesenchymal chondrosarcoma and the high-grade components of dedifferentiated chondrosarcoma can show some responsiveness to radiation therapy due to their more undifferentiated nature and higher cellularity. Therefore, radiation may be considered as an adjuvant or for unresectable disease in these specific variants. Radiation is not the primary treatment for conventional chondrosarcoma and is not contraindicated in all forms. It can be used for local control in some unresectable cases, not just for Grade I, and its role is not limited to palliation in metastatic disease, although that is one application.
Question 40:
A 60-year-old male with a history of radiation exposure for a prior malignancy develops a new, rapidly enlarging, painful mass in his ilium. Biopsy reveals a chondrosarcoma. What is the most likely etiology of this chondrosarcoma?
Options:
- Spontaneous primary chondrosarcoma.
- Malignant transformation of a pre-existing enchondroma.
- Radiation-induced chondrosarcoma.
- Malignant transformation of an osteochondroma.
- Mesenchymal chondrosarcoma.
Correct Answer: Radiation-induced chondrosarcoma.
Explanation:
Radiation exposure is a known risk factor for the development of secondary sarcomas, including chondrosarcoma. These radiation-induced sarcomas often present with a rapidly growing, painful mass within or near the previously irradiated field, typically many years after the initial radiation treatment. Given the patient's history, radiation-induced chondrosarcoma is the most likely etiology. While spontaneous primary chondrosarcoma is the most common type overall, the history of radiation is a strong indicator for this specific etiology. The other options are less likely given the specific history.
Question 41:
Which of the following is the most accurate statement regarding the role of positron emission tomography (PET) scans in chondrosarcoma?
Options:
- PET is the primary imaging modality for diagnosing chondrosarcoma.
- PET is highly sensitive for distinguishing between benign enchondroma and low-grade chondrosarcoma.
- PET is useful for assessing tumor metabolic activity, detecting distant metastases, and monitoring response to therapy in higher-grade lesions.
- PET is primarily used to assess bone marrow involvement.
- PET is superior to MRI for local staging of chondrosarcoma.
Correct Answer: PET is useful for assessing tumor metabolic activity, detecting distant metastases, and monitoring response to therapy in higher-grade lesions.
Explanation:
PET scans, particularly FDG-PET, are useful for assessing the metabolic activity of chondrosarcomas, which generally correlates with tumor grade (higher grade = higher uptake). It is valuable for detecting distant metastases (staging) and monitoring response to therapy, especially in higher-grade or dedifferentiated lesions. PET is not the primary diagnostic tool nor is it highly reliable for distinguishing low-grade chondrosarcoma from enchondroma due to overlapping SUV values. It is not superior to MRI for local staging.
Question 42:
What is the primary challenge in the pathological diagnosis of low-grade chondrosarcoma versus enchondroma?
Options:
- Distinguishing cartilaginous matrix from osteoid.
- Identifying mitotic figures, which are abundant in both.
- Assessing cellularity, nuclear atypia, and invasion of marrow spaces, which can be subtle.
- Identifying the presence of multinucleated giant cells.
- Differentiating it from fibrous tissue.
Correct Answer: Assessing cellularity, nuclear atypia, and invasion of marrow spaces, which can be subtle.
Explanation:
The distinction between low-grade chondrosarcoma and enchondroma is notoriously challenging for pathologists. It primarily relies on subtle features such as increased cellularity, nuclear plumpness and atypia, occasional binucleation, and crucially, the permeation of marrow fat spaces by malignant cells. Mitotic figures are typically sparse or absent even in low-grade chondrosarcoma. Giant cells are not characteristic of either. Distinguishing cartilaginous matrix from osteoid is for osteosarcoma, and from fibrous tissue for fibrous tumors.
Question 43:
A 55-year-old patient undergoes an intralesional curettage with adjuvant argon beam coagulation for a low-grade central chondrosarcoma of the proximal tibia. What is the most significant concern with this approach?
Options:
- Increased risk of pathological fracture.
- High rate of systemic metastasis.
- Difficulty with bone grafting.
- Increased risk of local recurrence due to incomplete tumor removal.
- Adverse reaction to argon gas.
Correct Answer: Increased risk of local recurrence due to incomplete tumor removal.
Explanation:
Intralesional curettage, even with adjuvant therapy like argon beam coagulation, carries a higher risk of local recurrence compared to wide en bloc resection for chondrosarcoma. Chondrosarcomas, even low-grade, can be infiltrative, and achieving truly negative margins intralesionally can be difficult. While not universally contraindicated in all low-grade central chondrosarcomas (especially in non-weight-bearing bones or expendable bones where wide resection is morbid), local recurrence is the primary concern. Systemic metastasis is rare for low-grade tumors. Pathological fracture or bone grafting issues are secondary concerns. Adverse reaction to argon gas is not a primary concern.
Question 44:
What is the characteristic appearance of a dedifferentiated chondrosarcoma on imaging?
Options:
- A uniformly well-circumscribed lesion with punctate calcifications.
- A purely sclerotic lesion with benign periosteal reaction.
- A biphasic appearance with a chondroid component juxtaposed with a destructive, aggressive lytic soft tissue mass.
- A lesion primarily affecting the epiphysis with clear cell morphology.
- A broad-based sessile lesion arising from the cortical surface.
Correct Answer: A biphasic appearance with a chondroid component juxtaposed with a destructive, aggressive lytic soft tissue mass.
Explanation:
Dedifferentiated chondrosarcoma typically presents with a biphasic imaging appearance, reflecting its histology. It shows features of a conventional chondrosarcoma (chondroid matrix, calcifications) adjacent to or within a more aggressive, destructive lytic lesion with cortical destruction and a significant soft tissue mass, representing the high-grade non-cartilaginous component. A uniformly well-circumscribed lesion or sclerotic lesion would suggest a low-grade or benign lesion. Epiphyseal clear cell morphology is for clear cell chondrosarcoma. A broad-based sessile lesion is characteristic of juxtacortical chondrosarcoma or osteochondroma.
Question 45:
Which molecular alteration is commonly associated with peripheral chondrosarcomas arising from osteochondromas?
Options:
- IDH1/IDH2 mutations.
- TP53 mutations.
- EXT1/EXT2 mutations.
- H3F3A mutations.
- COL2A1 mutations.
Correct Answer: EXT1/EXT2 mutations.
Explanation:
Peripheral chondrosarcomas, which arise from pre-existing osteochondromas (especially in Multiple Hereditary Exostoses), are strongly associated with inactivating mutations in the EXT1 and EXT2 genes. These genes are involved in heparan sulfate biosynthesis and are linked to the development of osteochondromas. While IDH1/IDH2 mutations are common in central chondrosarcomas and enchondromas, EXT1/EXT2 are specific to the osteochondroma pathway of malignant transformation.
Question 46:
A patient undergoing surveillance for Multiple Hereditary Exostoses (MHE) develops increasing pain in an osteochondroma of the pelvis. Which finding, if present, would prompt the most urgent concern for malignant transformation?
Options:
- A cartilaginous cap measuring 1.5 cm on MRI.
- Presence of a new bursal sac over the osteochondroma.
- Increased T2 signal within the cartilaginous cap without other aggressive features.
- New, irregular areas of calcification within the cartilaginous cap.
- Loss of continuity between the medulla of the osteochondroma and the parent bone.
Correct Answer: New, irregular areas of calcification within the cartilaginous cap.
Explanation:
While an adult cartilaginous cap >2-3 cm is concerning, new, irregular areas of calcification within the cartilaginous cap, especially when associated with pain and growth, are highly suspicious for malignant transformation and represent changes within the developing chondrosarcoma matrix. A 1.5 cm cap is generally within the benign range for MHE. A new bursa is a mechanical irritation, not malignancy. Increased T2 signal can be due to fluid or benign cartilage. Loss of medullary continuity is not typical for malignant transformation, which usually involves thickening of the cap or bony erosion.
Question 47:
What is the typical histological appearance of a Grade III conventional chondrosarcoma?
Options:
- Uniform cells with abundant intercellular matrix.
- Mildly increased cellularity with occasional binucleated cells.
- Marked cellular pleomorphism, high cellularity, obvious mitotic figures, and often necrosis.
- Small round cells with scant cytoplasm.
- Clear cells arranged in lobules with prominent reactive bone.
Correct Answer: Marked cellular pleomorphism, high cellularity, obvious mitotic figures, and often necrosis.
Explanation:
Grade III conventional chondrosarcoma is characterized by high cellularity, significant nuclear pleomorphism, obvious mitotic figures (which are rare in lower grades), and often areas of necrosis. This reflects its aggressive malignant nature. Uniform cells or mildly increased cellularity characterize lower grades. Small round cells are seen in mesenchymal chondrosarcoma. Clear cells are seen in clear cell chondrosarcoma.
Question 48:
What is the most common presenting symptom of an axial skeleton (e.g., pelvis, sacrum, spine) chondrosarcoma?
Options:
- Pathological fracture.
- Rapidly progressing neurological deficit.
- Deep, dull, persistent pain, often worse at night.
- Palpable mass that is mobile and non-tender.
- Acute onset severe pain with swelling.
Correct Answer: Deep, dull, persistent pain, often worse at night.
Explanation:
Axial skeleton chondrosarcomas often grow silently for a long time before symptoms appear. The most common presenting symptom is deep, dull, persistent pain, which may be worse at night and progressive. Pathological fractures can occur, but are less common than pain. Neurological deficits occur if the tumor compresses neural structures. A palpable mass might be present but often deep and fixed. Acute severe pain is less common unless there's a pathological fracture or rapid dedifferentiation.
Question 49:
In the surgical management of a low-grade chondrosarcoma, which approach, if feasible, is associated with the best long-term local control rates?
Options:
- Intralesional curettage.
- Marginal excision.
- Wide en bloc resection.
- Amputation.
- Radiation therapy alone.
Correct Answer: Wide en bloc resection.
Explanation:
Wide en bloc resection, achieving a clear margin of healthy tissue around the tumor, is associated with the best long-term local control rates for chondrosarcoma of all grades, including low-grade. While marginal excision can be considered for very select low-grade tumors and intralesional for specific situations, wide resection remains the gold standard for oncological safety. Amputation is a last resort. Radiation therapy alone is generally ineffective for conventional chondrosarcoma.
Question 50:
A 50-year-old male has an incidental finding of a lesion in his proximal humerus. Radiographs show punctate calcifications within a lobulated intramedullary lesion with mild endosteal scalloping. There is no pain. Biopsy confirms Grade I chondrosarcoma. What is the most appropriate management?
Options:
- Intralesional curettage.
- Wide en bloc resection of the proximal humerus.
- Observation with serial MRI scans.
- Radiation therapy.
- Systemic chemotherapy.
Correct Answer: Wide en bloc resection of the proximal humerus.
Explanation:
For a low-grade (Grade I) chondrosarcoma, particularly in the proximal humerus where limb salvage and functional preservation are paramount, wide en bloc resection is the most appropriate management to achieve local control. While observation might be considered for extremely indolent, asymptomatic enchondromas, a confirmed Grade I chondrosarcoma, even if asymptomatic, warrants definitive surgical treatment due to its malignant potential and risk of progression. Intralesional curettage may be considered in very selected, small, non-aggressive lesions where risks of wide resection are high, but wide resection offers the best local control. Radiation and chemotherapy are ineffective as primary treatments for conventional chondrosarcoma.
Question 51:
Which of the following is considered the gold standard for definitive staging of chondrosarcoma to identify distant metastases?
Options:
- Bone scan.
- CT scan of the chest, abdomen, and pelvis.
- MRI of the primary lesion.
- PET-CT.
- Plain radiographs of the entire skeleton.
Correct Answer: CT scan of the chest, abdomen, and pelvis.
Explanation:
For definitive staging of chondrosarcoma to identify distant metastases, a CT scan of the chest, abdomen, and pelvis is the gold standard. The lungs are the most common site of metastasis, making chest CT crucial. Abdomen/pelvis CT is important for other potential sites, especially for primary pelvic tumors. While PET-CT can be very useful for assessing metabolic activity and detecting metastases, CT of the chest is still generally considered the primary standard for lung metastasis detection. Bone scans are sensitive but non-specific and may not pick up all metastases. MRI is for local staging.
Question 52:
What is a potential complication of intralesional curettage for chondrosarcoma, even with adjuvant therapy?
Options:
- Increased systemic toxicity.
- Reduced joint function due to excessive bone removal.
- Persistent pain requiring long-term opioid use.
- Local recurrence at the surgical site.
- Accelerated malignant transformation.
Correct Answer: Local recurrence at the surgical site.
Explanation:
The most significant and well-documented complication of intralesional curettage for chondrosarcoma is local recurrence at the surgical site. This is due to the infiltrative nature of the tumor cells and the difficulty of achieving truly clear margins with this technique. While intralesional curettage aims to preserve joint function, incomplete tumor removal increases recurrence risk, which can be more challenging to manage. The other options are less direct or less common complications of this specific surgical approach.
Question 53:
A patient is diagnosed with a Grade II chondrosarcoma of the proximal femur. Considering its location and grade, what factor will most significantly influence the decision between limb salvage and amputation?
Options:
- Patient's age and comorbidities.
- Size of the tumor and its extent of extraosseous involvement.
- Presence of a pathological fracture.
- Patient's preference for a specific type of reconstruction.
- Availability of adjuvant chemotherapy.
Correct Answer: Size of the tumor and its extent of extraosseous involvement.
Explanation:
The size of the tumor and its extent of extraosseous involvement, particularly compromise of the neurovascular bundle or significant muscle groups, are the most critical factors determining the feasibility of limb salvage versus amputation for a proximal femur chondrosarcoma. If wide surgical margins cannot be achieved without sacrificing essential neurovascular structures or if the tumor is too extensive to reconstruct functionally, amputation becomes necessary. While patient's age and preferences are important, they are secondary to oncological principles and surgical feasibility.
Question 54:
Which of the following describes the most common type of chondrosarcoma to affect the small bones of the hands and feet?
Options:
- Dedifferentiated chondrosarcoma.
- Mesenchymal chondrosarcoma.
- Periosteal chondrosarcoma.
- Secondary chondrosarcoma arising from a solitary osteochondroma.
- Secondary chondrosarcoma arising from enchondromatosis (e.g., Ollier's disease).
Correct Answer: Secondary chondrosarcoma arising from enchondromatosis (e.g., Ollier's disease).
Explanation:
While conventional chondrosarcoma can occur in the small bones, malignant transformation of enchondromas, particularly in the context of enchondromatosis (Ollier's disease or Maffucci's syndrome), is the most common cause of chondrosarcoma in the small bones of the hands and feet. These typically present as low-grade chondrosarcomas. Other variants are less common in these locations.
Question 55:
A 45-year-old female presents with a lesion in the vertebral body. Biopsy indicates a chondrosarcoma. Which of the following features would histologically favor a low-grade conventional chondrosarcoma over a chordoma, which can also occur in this location?
Options:
- Presence of physaliferous cells.
- Immunoreactivity for S-100 protein.
- Absence of extracellular myxoid matrix.
- Presence of cytokeratin positivity.
- Location in the clivus.
Correct Answer: Immunoreactivity for S-100 protein.
Explanation:
Both chondrosarcoma and chordoma can occur in the vertebral body and both can show S-100 positivity, but chondrosarcoma typically shows stronger and more widespread S-100 immunoreactivity. However, the presence of physaliferous cells (vacuolated cells with bubbly cytoplasm) and cytokeratin positivity are classic immunohistochemical and histological hallmarks of chordoma. Chondrosarcomas have a chondroid (cartilaginous) matrix, which is different from the abundant myxoid matrix of chordoma. Clivus location is more classic for chordoma. Therefore, the presence of physaliferous cells or strong cytokeratin positivity would lean towards chordoma.
Question 56:
In a patient with a suspected chondrosarcoma, which of the following statements about bone scintigraphy (bone scan) is most accurate?
Options:
- It is specific for chondrosarcoma diagnosis.
- It can reliably differentiate between enchondroma and low-grade chondrosarcoma.
- It is primarily used to detect multifocal disease or skeletal metastases.
- It is superior to MRI for assessing local tumor extent.
- It is not indicated for cartilaginous tumors due to low metabolic activity.
Correct Answer: It is primarily used to detect multifocal disease or skeletal metastases.
Explanation:
Bone scintigraphy (bone scan) is highly sensitive for detecting areas of increased bone turnover, which can occur in both benign and malignant bone lesions. Its primary role in chondrosarcoma is for screening for multifocal disease (e.g., in syndromes like MHE or Ollier's) or detecting skeletal metastases. It is not specific for diagnosis, cannot reliably differentiate low-grade chondrosarcoma from enchondroma (as both can show increased uptake), and is inferior to MRI for local tumor extent assessment. While chondrosarcomas generally have lower metabolic activity than other sarcomas, they still typically show uptake on bone scan.
Question 57:
What is the typical growth pattern of a low-grade conventional chondrosarcoma?
Options:
- Rapidly destructive with extensive soft tissue involvement.
- Slow-growing, often expanding the cortex and permeating marrow spaces.
- Aggressively permeative, skipping entire bone segments.
- Strictly contained within the cartilage cap, never invading bone.
- Purely exophytic, arising from the periosteum.
Correct Answer: Slow-growing, often expanding the cortex and permeating marrow spaces.
Explanation:
Low-grade conventional chondrosarcomas are typically slow-growing tumors. They gradually expand the bone, leading to cortical thickening or erosion, and have a characteristic infiltrative growth pattern where tumor cells permeate the marrow spaces. Rapid destruction or aggressive skipping patterns are more typical of high-grade or other aggressive sarcomas. While juxtacortical chondrosarcomas are exophytic, conventional chondrosarcomas are intramedullary. The cartilage cap refers to osteochondromas, not conventional chondrosarcomas.
Question 58:
A 28-year-old male presents with a painful mass in the pubic symphysis. Imaging shows a large lesion with chondroid matrix. Biopsy reveals a mesenchymal chondrosarcoma. Which adjuvant treatment is most appropriate for this patient following wide surgical resection?
Options:
- No adjuvant therapy is typically needed.
- Systemic chemotherapy.
- Radiation therapy alone.
- Targeted therapy with IDH inhibitors.
- Local cryoablation.
Correct Answer: Systemic chemotherapy.
Explanation:
Mesenchymal chondrosarcoma is a high-grade, aggressive tumor that, unlike conventional chondrosarcoma, is responsive to chemotherapy. Therefore, systemic chemotherapy is typically recommended as an adjuvant therapy following wide surgical resection to address micrometastatic disease and improve survival. Radiation therapy may also be used, especially for positive margins or unresectable disease, but chemotherapy is often primary for systemic control. IDH inhibitors are not indicated for mesenchymal chondrosarcoma. Local cryoablation is not adequate for such an aggressive tumor.
Question 59:
Which of the following factors would lead to the poorest prognosis for a patient with chondrosarcoma?
Options:
- Primary tumor located in a long bone.
- Histological diagnosis of Grade I conventional chondrosarcoma.
- Negative surgical margins (R0 resection).
- Presence of distant metastases at presentation.
- Patient age less than 40 years.
Correct Answer: Presence of distant metastases at presentation.
Explanation:
The presence of distant metastases at presentation is the most significant negative prognostic factor for any sarcoma, including chondrosarcoma. It indicates advanced disease and is associated with significantly poorer survival rates compared to localized disease, regardless of tumor grade or location. Grade I conventional chondrosarcoma with negative margins in a long bone generally has a good prognosis. Patient age can be a factor but is secondary to metastatic disease.
Question 60:
A 60-year-old female presents with a painful shoulder mass. Biopsy reveals a Grade II chondrosarcoma of the proximal humerus. Preoperative workup should include which of the following for staging?
Options:
- Only local radiographs of the shoulder.
- MRI of the shoulder and CT scan of the chest.
- PET-CT scan of the entire body.
- Bone scan only.
- Ultrasound of regional lymph nodes.
Correct Answer: MRI of the shoulder and CT scan of the chest.
Explanation:
Preoperative staging for a Grade II chondrosarcoma should include local imaging with MRI to precisely delineate tumor extent for surgical planning, and a CT scan of the chest to rule out lung metastases, which is the most common site of distant spread. While a PET-CT can provide additional information, CT chest for lung metastases and local MRI are the core staging modalities. Bone scan and regional lymph node ultrasound are less routinely critical for conventional chondrosarcoma in this context.
Question 61:
What is the primary role of percutaneous biopsy in the diagnosis of chondrosarcoma?
Options:
- To provide definitive treatment.
- To distinguish between Grade I and Grade III lesions without risk of sampling error.
- To obtain tissue for histological diagnosis and grading prior to definitive surgical planning.
- To assess tumor response to neoadjuvant chemotherapy.
- To definitively rule out infection.
Correct Answer: To obtain tissue for histological diagnosis and grading prior to definitive surgical planning.
Explanation:
The primary role of percutaneous biopsy (core needle biopsy or incisional biopsy if core is insufficient) in chondrosarcoma is to obtain tissue for accurate histological diagnosis and grading prior to definitive surgical planning. This is crucial as management strategies vary significantly based on the diagnosis and grade. It is not for definitive treatment, can have sampling error in distinguishing grades (especially low vs. high), and is not solely for assessing therapy response or ruling out infection (though it can help).
